- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Ex-employee alleged an RBM pushed sales staff to pressure prescribers using medico-legal “you might be sued” messaging for Latuda. Panel found RBM…
Two near-identical MSD Connect emails with different subject lines were sent within seconds due to a third-party technical error. Panel found no…
Anonymous employee alleged Biogen paid “huge” sales bonuses/incentives. Panel initially found breach of 15.7 and 9.1 for a 50–60% bonus outlier, but…
Vifor’s CMO proactively discussed a comparative safety paper with HCPs. Panel found one call’s promotional nature was disguised (Clause 12.1) and the…
GSK admitted a certified promotional email for Trelegy Ellipta included prescribing information dated Nov 2017 instead of the current Nov 2018 SPC.…
Bayer-funded ‘Prescribing Policy’ positioning vardenafil as first choice was ruled promotional, lacked prescribing information and triggered audits, recovery of items and a…
Takeda challenged AstraZeneca’s “No other LHRHa has demonstrated survival benefits in all 3 stages…” claim in a Zoladex price-reduction letter. The PMCPA…
A prescriber mailing for Nicorette QuickMist was ruled misleading: “60 second craving relief” was juxtaposed with “breakthrough cravings”, and a £1.23/day cost…
A Tysabri patient DVD was manufactured with a third-party error and contained promotional content for Leo’s Xamiol Gel (a POM). PMCPA found…
Anonymous complaint alleged a Chugai rep boasted Granocyte business was ‘wrapped up’ via consultant ‘pay offs’. Chugai’s investigation found only three legitimate…
UCB placed an advertorial-style piece in a Times Parkinson’s supplement naming Keppra and Neupro (POMs). It was released without proper approval/certification and…
PMCPA case AUTH/3075/9/18 (Director v Lundbeck) concerned clinical trial disclosure but was ruled outwith the scope of the ABPI Code (2016). No…
A physician challenged a £300-paid invitation to assess sales reps as “underhand”. Panel initially found disguised promotion and inducement concerns, but the…
A GP challenged Pradaxa.co.uk access controls and content. PMCPA found no public advertising and no misleading dose issue, but ruled a breach…
J&J leavepiece for Nicorette Invisi Patch used tick/cross comparisons vs varenicline and a bar chart from an observational study. PMCPA found misleading…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.